Calcium-Phosphorus Regulation Therapy on Heart Valve Disease

NCT06660524 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

196

Enrollment

OTHER_GOV

Sponsor class

Conditions

Degenerative Heart Valve Disease
Heart Valve Calcification
Chronic Kidney Disease(CKD)
Calcium-Phosphorus Metabolism Disorders

Interventions

DRUG: Sevelamer
DRUG: Calcium carbonate

Sponsor

China National Center for Cardiovascular Diseases